<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-17" modified="2020-10-07" version="140">
<accession>Q53GL7</accession>
<accession>Q8N2I0</accession>
<accession>Q8WV05</accession>
<accession>Q96CH7</accession>
<accession>Q96K72</accession>
<name>PAR10_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="19">Protein mono-ADP-ribosyltransferase PARP10</fullName>
<ecNumber evidence="12 17">2.4.2.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="18">ADP-ribosyltransferase diphtheria toxin-like 10</fullName>
<shortName evidence="18">ARTD10</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="18">Poly [ADP-ribose] polymerase 10</fullName>
<shortName evidence="18">PARP-10</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="21">PARP10</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ALA-630</scope>
<source>
<tissue>Mammary gland</tissue>
<tissue>Thyroid</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 357-1025</scope>
<source>
<tissue>Skin</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="1982" last="1993">
<title>PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.</title>
<authorList>
<person name="Yu M."/>
<person name="Schreek S."/>
<person name="Cerni C."/>
<person name="Schamberger C."/>
<person name="Lesniewicz K."/>
<person name="Poreba E."/>
<person name="Vervoorts J."/>
<person name="Walsemann G."/>
<person name="Groetzinger J."/>
<person name="Kremmer E."/>
<person name="Mehraein Y."/>
<person name="Mertsching J."/>
<person name="Kraft R."/>
<person name="Austen M."/>
<person name="Luescher-Firzlaff J."/>
<person name="Luescher B."/>
</authorList>
<dbReference type="PubMed" id="15674325"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208410"/>
</citation>
<scope>IDENTIFICATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH MYC</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="15201" last="15207">
<title>CDK-dependent activation of poly(ADP-ribose) polymerase member 10 (PARP10).</title>
<authorList>
<person name="Chou H.Y."/>
<person name="Chou H.T."/>
<person name="Lee S.C."/>
</authorList>
<dbReference type="PubMed" id="16455663"/>
<dbReference type="DOI" id="10.1074/jbc.m506745200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-101</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="57" last="69">
<title>Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation.</title>
<authorList>
<person name="Kleine H."/>
<person name="Poreba E."/>
<person name="Lesniewicz K."/>
<person name="Hassa P.O."/>
<person name="Hottiger M.O."/>
<person name="Litchfield D.W."/>
<person name="Shilton B.H."/>
<person name="Luescher B."/>
</authorList>
<dbReference type="PubMed" id="18851833"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.08.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ADP-RIBOSYLATION AT GLU-882</scope>
<scope>MUTAGENESIS OF GLU-882; GLY-888; 980-ASP--ILE-982; PRO-985; ILE-987 AND THR-999</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-916</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Trends Biochem. Sci." volume="35" first="208" last="219">
<title>Toward a unified nomenclature for mammalian ADP-ribosyltransferases.</title>
<authorList>
<person name="Hottiger M.O."/>
<person name="Hassa P.O."/>
<person name="Luscher B."/>
<person name="Schuler H."/>
<person name="Koch-Nolte F."/>
</authorList>
<dbReference type="PubMed" id="20106667"/>
<dbReference type="DOI" id="10.1016/j.tibs.2009.12.003"/>
</citation>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663 AND SER-1011</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2013" name="Cell Commun. Signal." volume="11" first="5" last="5">
<title>ARTD10 substrate identification on protein microarrays: regulation of GSK3beta by mono-ADP-ribosylation.</title>
<authorList>
<person name="Feijs K.L."/>
<person name="Kleine H."/>
<person name="Braczynski A."/>
<person name="Forst A.H."/>
<person name="Herzog N."/>
<person name="Verheugd P."/>
<person name="Linzen U."/>
<person name="Kremmer E."/>
<person name="Luscher B."/>
</authorList>
<dbReference type="PubMed" id="23332125"/>
<dbReference type="DOI" id="10.1186/1478-811x-11-5"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="502" last="507">
<title>Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases.</title>
<authorList>
<person name="Rosenthal F."/>
<person name="Feijs K.L."/>
<person name="Frugier E."/>
<person name="Bonalli M."/>
<person name="Forst A.H."/>
<person name="Imhof R."/>
<person name="Winkler H.C."/>
<person name="Fischer D."/>
<person name="Caflisch A."/>
<person name="Hassa P.O."/>
<person name="Luescher B."/>
<person name="Hottiger M.O."/>
</authorList>
<dbReference type="PubMed" id="23474714"/>
<dbReference type="DOI" id="10.1038/nsmb.2521"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="Structure" volume="21" first="462" last="475">
<title>Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8 macrodomains.</title>
<authorList>
<person name="Forst A.H."/>
<person name="Karlberg T."/>
<person name="Herzog N."/>
<person name="Thorsell A.G."/>
<person name="Gross A."/>
<person name="Feijs K.L."/>
<person name="Verheugd P."/>
<person name="Kursula P."/>
<person name="Nijmeijer B."/>
<person name="Kremmer E."/>
<person name="Kleine H."/>
<person name="Ladurner A.G."/>
<person name="Schuler H."/>
<person name="Luscher B."/>
</authorList>
<dbReference type="PubMed" id="23473667"/>
<dbReference type="DOI" id="10.1016/j.str.2012.12.019"/>
</citation>
<scope>INTERACTION WITH PARP14</scope>
<scope>MUTAGENESIS OF GLY-888</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378; SER-423; SER-431 AND SER-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="13627" last="13637">
<title>The ADP-ribosyltransferase PARP10/ARTD10 interacts with proliferating cell nuclear antigen (PCNA) and is required for DNA damage tolerance.</title>
<authorList>
<person name="Nicolae C.M."/>
<person name="Aho E.R."/>
<person name="Vlahos A.H."/>
<person name="Choe K.N."/>
<person name="De S."/>
<person name="Karras G.I."/>
<person name="Moldovan G.L."/>
</authorList>
<dbReference type="PubMed" id="24695737"/>
<dbReference type="DOI" id="10.1074/jbc.m114.556340"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PCNA</scope>
<scope>MUTAGENESIS OF 650-LEU--GLN-690; 831-GLN--TYR-838 AND GLY-888</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="4426" last="4426">
<title>Family-wide analysis of poly(ADP-ribose) polymerase activity.</title>
<authorList>
<person name="Vyas S."/>
<person name="Matic I."/>
<person name="Uchima L."/>
<person name="Rood J."/>
<person name="Zaja R."/>
<person name="Hay R.T."/>
<person name="Ahel I."/>
<person name="Chang P."/>
</authorList>
<dbReference type="PubMed" id="25043379"/>
<dbReference type="DOI" id="10.1038/ncomms5426"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ADP-RIBOSYLATION AT GLU-106; LYS-140 AND LYS-916</scope>
</reference>
<reference key="16">
<citation type="submission" date="2007-02" db="PDB data bank">
<title>Solution structure of the RRM domain in the human poly (ADP-ribose) polymerase family, member 10 variant.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 7-101</scope>
</reference>
<reference key="17">
<citation type="submission" date="2009-06" db="PDB data bank">
<title>Human poly(ADP-ribose) polymerase 10, catalytic fragment in complex with an inhibitor 3-aminobenzamide.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 809-1017</scope>
</reference>
<comment type="function">
<text evidence="12 13 15 16 17">ADP-ribosyltransferase that mediates mono-ADP-ribosylation of glutamate and aspartate residues on target proteins (PubMed:18851833, PubMed:23332125, PubMed:23474714, PubMed:25043379). In contrast to PARP1 and PARP2, it is not able to mediate poly-ADP-ribosylation (PubMed:18851833). Catalyzes mono-ADP-ribosylation of GSK3B, leading to negatively regulate GSK3B kinase activity (PubMed:23332125). Involved in translesion DNA synthesis in response to DNA damage via its interaction with PCNA (PubMed:24695737).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="17">
<text>L-lysyl-[protein] + NAD(+) = H(+) + N(6)-(ADP-D-ribosyl)-L-lysyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:58220"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:15088"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:142515"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="17">
<dbReference type="Rhea" id="RHEA:58221"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12">
<text>L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-aspartyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:54424"/>
<dbReference type="Rhea" id="RHEA-COMP:9867"/>
<dbReference type="Rhea" id="RHEA-COMP:13832"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29961"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:138102"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="12">
<dbReference type="Rhea" id="RHEA:54425"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 17">
<text>L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-glutamyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:58224"/>
<dbReference type="Rhea" id="RHEA-COMP:10208"/>
<dbReference type="Rhea" id="RHEA-COMP:15089"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29973"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:142540"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="12 17">
<dbReference type="Rhea" id="RHEA:58225"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="10 14 16">Interacts with MYC (PubMed:15674325). Interacts with PARP14 (PubMed:23473667). Interacts (via-PIP box and ubiquitin-interacting motifs) with PCNA (PubMed:24695737).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2857573">
<id>Q53GL7</id>
</interactant>
<interactant intactId="EBI-8502288">
<id>Q9Y530</id>
<label>OARD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Nucleus</location>
<location evidence="10">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cytoplasm</location>
</subcellularLocation>
<text evidence="10">Shuttles between the nuclear and cytoplasmic compartment (PubMed:15674325). A subpopulation concentrates in the nucleolus during late G1/S phase (PubMed:15674325).</text>
</comment>
<comment type="tissue specificity">
<text evidence="10">Highly expressed in spleen and thymus (PubMed:15674325). Intermediate levels in liver, kidney, pancreas, prostate, testis, ovary, intestine, and leukocytes (PubMed:15674325). Low expression in heart, brain, placenta, lung, skeletal muscle, and colon (PubMed:15674325).</text>
</comment>
<comment type="domain">
<text evidence="16">The PIP-box mediates the interaction with PCNA.</text>
</comment>
<comment type="PTM">
<text evidence="11">Stimulated through its phosphorylation by CDK2 (PubMed:16455663). Acquires CDK-dependent phosphorylation through late-G1 to S phase, and from prometaphase to cytokinesis in the nucleolar organizing regions (PubMed:16455663). Phosphorylation is suppressed in growth-arrested cells (PubMed:16455663).</text>
</comment>
<comment type="PTM">
<text evidence="12 17">Auto-mono-ADP-ribosylated on glutamate and lysine residues.</text>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="BAC11498" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="2.4.2.-" evidence="12 17"/>
<dbReference type="EMBL" id="AK027370">
<property type="protein sequence ID" value="BAB55067.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK075250">
<property type="protein sequence ID" value="BAC11498.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222914">
<property type="protein sequence ID" value="BAD96634.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014229">
<property type="protein sequence ID" value="AAH14229.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC019030">
<property type="protein sequence ID" value="AAH19030.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34960.1"/>
<dbReference type="RefSeq" id="NP_116178.2">
<property type="nucleotide sequence ID" value="NM_032789.4"/>
</dbReference>
<dbReference type="PDB" id="2DHX">
<property type="method" value="NMR"/>
<property type="chains" value="A=10-100"/>
</dbReference>
<dbReference type="PDB" id="3HKV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=809-1017"/>
</dbReference>
<dbReference type="PDB" id="5LX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="A/B=819-1007"/>
</dbReference>
<dbReference type="PDB" id="6FXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=819-1007"/>
</dbReference>
<dbReference type="PDBsum" id="2DHX"/>
<dbReference type="PDBsum" id="3HKV"/>
<dbReference type="PDBsum" id="5LX6"/>
<dbReference type="PDBsum" id="6FXI"/>
<dbReference type="SMR" id="Q53GL7"/>
<dbReference type="BioGRID" id="124320">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="IntAct" id="Q53GL7">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="MINT" id="Q53GL7"/>
<dbReference type="STRING" id="9606.ENSP00000325618"/>
<dbReference type="BindingDB" id="Q53GL7"/>
<dbReference type="ChEMBL" id="CHEMBL2429708"/>
<dbReference type="DrugCentral" id="Q53GL7"/>
<dbReference type="iPTMnet" id="Q53GL7"/>
<dbReference type="PhosphoSitePlus" id="Q53GL7"/>
<dbReference type="BioMuta" id="PARP10"/>
<dbReference type="DMDM" id="116248563"/>
<dbReference type="EPD" id="Q53GL7"/>
<dbReference type="jPOST" id="Q53GL7"/>
<dbReference type="MassIVE" id="Q53GL7"/>
<dbReference type="MaxQB" id="Q53GL7"/>
<dbReference type="PaxDb" id="Q53GL7"/>
<dbReference type="PeptideAtlas" id="Q53GL7"/>
<dbReference type="PRIDE" id="Q53GL7"/>
<dbReference type="ProteomicsDB" id="62485"/>
<dbReference type="Antibodypedia" id="28206">
<property type="antibodies" value="100 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000313028">
<property type="protein sequence ID" value="ENSP00000325618"/>
<property type="gene ID" value="ENSG00000178685"/>
</dbReference>
<dbReference type="GeneID" id="84875"/>
<dbReference type="KEGG" id="hsa:84875"/>
<dbReference type="UCSC" id="uc003zal.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="84875"/>
<dbReference type="DisGeNET" id="84875"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000178685.13"/>
<dbReference type="GeneCards" id="PARP10"/>
<dbReference type="HGNC" id="HGNC:25895">
<property type="gene designation" value="PARP10"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000178685">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="609564">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q53GL7"/>
<dbReference type="OpenTargets" id="ENSG00000178685"/>
<dbReference type="PharmGKB" id="PA134892853"/>
<dbReference type="eggNOG" id="ENOG502R572">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162035"/>
<dbReference type="InParanoid" id="Q53GL7"/>
<dbReference type="KO" id="K15261"/>
<dbReference type="PhylomeDB" id="Q53GL7"/>
<dbReference type="TreeFam" id="TF328965"/>
<dbReference type="PathwayCommons" id="Q53GL7"/>
<dbReference type="Reactome" id="R-HSA-197264">
<property type="pathway name" value="Nicotinamide salvaging"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="84875">
<property type="hits" value="17 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PARP10">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q53GL7"/>
<dbReference type="GeneWiki" id="PARP10"/>
<dbReference type="GenomeRNAi" id="84875"/>
<dbReference type="Pharos" id="Q53GL7">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q53GL7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="RNAct" id="Q53GL7">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000178685">
<property type="expression patterns" value="Expressed in tendon of biceps brachii and 202 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q53GL7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q53GL7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070530">
<property type="term" value="F:K63-linked polyubiquitin modification-dependent protein binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003950">
<property type="term" value="F:NAD+ ADP-ribosyltransferase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990404">
<property type="term" value="F:protein ADP-ribosylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034356">
<property type="term" value="P:NAD biosynthesis via nicotinamide riboside salvage pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900045">
<property type="term" value="P:negative regulation of protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006471">
<property type="term" value="P:protein ADP-ribosylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070213">
<property type="term" value="P:protein auto-ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0140289">
<property type="term" value="P:protein mono-ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070212">
<property type="term" value="P:protein poly-ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010847">
<property type="term" value="P:regulation of chromatin assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019985">
<property type="term" value="P:translesion synthesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd12547">
<property type="entry name" value="RRM1_2_PAR10"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.330">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR012677">
<property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034464">
<property type="entry name" value="PAR10_RRM1_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR012317">
<property type="entry name" value="Poly(ADP-ribose)pol_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00644">
<property type="entry name" value="PARP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51059">
<property type="entry name" value="PARP_CATALYTIC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0328">Glycosyltransferase</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Protein mono-ADP-ribosyltransferase PARP10" id="PRO_0000252435">
<location>
<begin position="1"/>
<end position="1025"/>
</location>
</feature>
<feature type="domain" description="PARP catalytic" evidence="8">
<location>
<begin position="806"/>
<end position="1025"/>
</location>
</feature>
<feature type="region of interest" description="Myc binding" evidence="10">
<location>
<begin position="700"/>
<end position="907"/>
</location>
</feature>
<feature type="short sequence motif" description="Ubiquitin-interacting" evidence="20">
<location>
<begin position="650"/>
<end position="667"/>
</location>
</feature>
<feature type="short sequence motif" description="Ubiquitin-interacting" evidence="20">
<location>
<begin position="673"/>
<end position="690"/>
</location>
</feature>
<feature type="short sequence motif" description="PIP-box" evidence="16">
<location>
<begin position="831"/>
<end position="838"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="588"/>
<end position="697"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosyl glutamic acid" evidence="17">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="N6-(ADP-ribosyl)lysine" evidence="17">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="378"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7">
<location>
<position position="663"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosyl glutamic acid" evidence="12">
<location>
<position position="882"/>
</location>
</feature>
<feature type="modified residue" description="N6-(ADP-ribosyl)lysine" evidence="17">
<location>
<position position="916"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="5">
<location>
<position position="916"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="1011"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11136344." id="VAR_027859">
<original>I</original>
<variation>V</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11136343." id="VAR_027860">
<original>L</original>
<variation>P</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11544989." id="VAR_027861" evidence="9">
<original>V</original>
<variation>A</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with PCNA." evidence="16">
<location>
<begin position="650"/>
<end position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PCNA." evidence="16">
<original>QEVVRAFY</original>
<variation>AEVARAAA</variation>
<location>
<begin position="831"/>
<end position="838"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased auto-mono-ADP-ribosylation." evidence="12">
<original>E</original>
<variation>A</variation>
<location>
<position position="882"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes catalytic activity; abolishes interaction with PARP14." evidence="12 14 16">
<original>G</original>
<variation>W</variation>
<location>
<position position="888"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased catalytic activity." evidence="12">
<original>DCI</original>
<variation>ACA</variation>
<location>
<begin position="980"/>
<end position="982"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased catalytic activity." evidence="12">
<original>P</original>
<variation>A</variation>
<location>
<position position="985"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased catalytic activity." evidence="12">
<original>I</original>
<variation>E</variation>
<location>
<position position="987"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect catalytic activity." evidence="12">
<original>T</original>
<variation>A</variation>
<location>
<position position="999"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAB55067." ref="1" evidence="19">
<original>M</original>
<variation>I</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAB55067." ref="1" evidence="19">
<original>P</original>
<variation>S</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAH14229." ref="3" evidence="19">
<original>L</original>
<variation>P</variation>
<location>
<position position="813"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAB55067." ref="1" evidence="19">
<original>R</original>
<variation>K</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAD96634." ref="2" evidence="19">
<original>D</original>
<variation>G</variation>
<location>
<position position="1013"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="12"/>
<end position="17"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="24"/>
<end position="32"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="34"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="59"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="819"/>
<end position="822"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="825"/>
<end position="827"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="828"/>
<end position="839"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="842"/>
<end position="844"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="845"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="848"/>
<end position="856"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="859"/>
<end position="875"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="877"/>
<end position="879"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="883"/>
<end position="889"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="891"/>
<end position="893"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="894"/>
<end position="900"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="904"/>
<end position="906"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="916"/>
<end position="923"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="924"/>
<end position="927"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="930"/>
<end position="932"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="941"/>
<end position="948"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="952"/>
<end position="955"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="961"/>
<end position="963"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="971"/>
<end position="974"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="976"/>
<end position="980"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="982"/>
<end position="984"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="987"/>
<end position="990"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="995"/>
<end position="1006"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DHX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HKV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LX6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6FXI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00397"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15674325"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16455663"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18851833"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23332125"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23473667"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23474714"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24695737"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25043379"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20106667"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<evidence key="20" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24695737"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:25895"/>
</source>
</evidence>
<sequence length="1025" mass="109998" checksum="AC9CCFCF9B83A989" modified="2006-10-17" version="2">MVAMAEAEAGVAVEVRGLPPAVPDELLTLYFENRRRSGGGPVLSWQRLGCGGVLTFREPADAERVLAQADHELHGAQLSLRPAPPRAPARLLLQGLPPGTTPQRLEQHVQALLRASGLPVQPCCALASPRPDRALVQLPKPLSEADVRVLEEQAQNLGLEGTLVSLARVPQARAVRVVGDGASVDLLLLELYLENERRSGGGPLEDLQRLPGPLGTVASFQQWQVAERVLQQEHRLQGSELSLVPHYDILEPEELAENTSGGDHPSTQGPRATKHALLRTGGLVTALQGAGTVTMGSGEEPGQSGASLRTGPMVQGRGIMTTGSGQEPGQSGTSLRTGPMGSLGQAEQVSSMPMGSLEHEGLVSLRPVGLQEQEGPMSLGPVGSAGPVETSKGLLGQEGLVEIAMDSPEQEGLVGPMEITMGSLEKAGPVSPGCVKLAGQEGLVEMVLLMEPGAMRFLQLYHEDLLAGLGDVALLPLEGPDMTGFRLCGAQASCQAAEEFLRSLLGSISCHVLCLEHPGSARFLLGPEGQHLLQGLEAQFQCVFGTERLATATLDTGLEEVDPTEALPVLPGNAHTLWTPDSTGGDQEDVSLEEVRELLATLEGLDLDGEDWLPRELEEEGPQEQPEEEVTPGHEEEEPVAPSTVAPRWLEEEAALQLALHRSLEPQGQVAEQEEAAALRQALTLSLLEQPPLEAEEPPDGGTDGKAQLVVHSAFEQDVEELDRALRAALEVHVQEETVGPWRRTLPAELRARLERCHGVSVALRGDCTILRGFGAHPARAARHLVALLAGPWDQSLAFPLAASGPTLAGQTLKGPWNNLERLAENTGEFQEVVRAFYDTLDAARSSIRVVRVERVSHPLLQQQYELYRERLLQRCERRPVEQVLYHGTTAPAVPDICAHGFNRSFCGRNATVYGKGVYFARRASLSVQDRYSPPNADGHKAVFVARVLTGDYGQGRRGLRAPPLRGPGHVLLRYDSAVDCICQPSIFVIFHDTQALPTHLITCEHVPRASPDDPSGLPGRSPDT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

